News
Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...
StockStory.org on MSN8d
Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after a new trade agreement between the United States and ...
Mount Gilead earned a boys track and field district championship on May 24, running its streak to four in a row. This is how MG pulled it off.
Kahlenberg reports receiving consulting fees from Biogen, Boehringer Ingelheim, Eli Lilly & Co., EMD Serono, Exo Therapeutics, Gilead Sciences, GlaxoSmithKline, Lupus Therapeutics, Related Science ...
The global CAR T-Cell therapy for non-hodgkin’s lymphoma market is driven by clinical innovation, rising prevalence, and demand for durable treatments in relapsed cases.
Bicycle Therapeutics BCYC underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings ...
Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate settlement with Gilead Sciences, Inc. over an illegal kickback scheme to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results